NJ-based Johnson & Johnson plans to have COVID-19 vaccines for 100 million Americans by April
New Brunswick-based Johnson & Johnson is planning to have enough COVID-19 vaccines for 100 million Americans by April.
The company is currently conducting a trial to make sure its vaccine is safe and effective.
Dr. Anthony Fauci says it’s close to seeking an emergency use authorization from the FDA.
Johnson & Johnson's vaccine is a single shot and doesn't need to be stored in temperatures as cold as Pfizer and Moderna shots.